Confluentibus Reticulatis Papillomatosis (Confluent reticulated papillomatosis) rarissima est, sed distinctiva acquisita ichthyosiformia dermatosis, propria persistente obscuro, squamosa, inaequaliter quae in trunco centrali praecipue locali tendunt. Morbus a Minocyclino curari potest.
Confluent and reticulated papillomatosis of Gougerot and Carteaud is an uncommon but distinctive acquired ichthyosiform dermatosis characterized by persistent dark, scaly, papules and plaques that tend to be localized predominantly on the central trunk.
☆ In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
Casus typicus ― Apparet maculam pigmentatam nigram cum nulla symptomata (pruritio, dolor) circa umbilicum.
Confluent and reticulated papillomatosis (CRP) , etiam syndrome Gougerot-Carteaud vocatur, ex abnormis cutis cellae incremento provenit. Notae sunt maculae sine dolore obscurae quae in majores inaequalitates misceri possunt, apparentes plerumque in pectore superiore et collo eleifend et iuvenibus adultis. Praecipua curationis electio est minocyclina. Confluent and reticulated papillomatosis (CRP), also known as Gougerot-Carteaud syndrome, is caused by disordered keratinization. It presents with asymptomatic hyperpigmented papules that can coalesce into plaques and are typically located on the upper trunk and neck of teens and young adults. First-line treatment is oral 'minocycline'.
CRP plerumque apparent sicut maculae obscurae et inaequaliter sine symptomata in cute circa collum, alis, pectus superius, et dorsum superius. Aliquando potest ad frontem usque ad pubem. Antibiotici sicut minocycline facti praelati electionis curationi sunt. CRP typically presents as asymptomatic hyperpigmented papules and plaques with peripheral reticulation over the nape, axillae, upper chest, and upper back, occasionally with extension superior to the forehead and inferior to the pubic region. Antibiotics, such as 'minocycline', at anti-inflammatory doses have emerged as a preferred therapeutic option.
○ Curatio
#Minocycline